You have 6 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Monoclonal Antibody Treatment

Showing 26 - 50 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Primary Immune Thrombocytopenia (ITP) Trial in Tianjin (TPO-RAs, TPO-RAs combining anti-CD 20 mAb)

Not yet recruiting
  • Primary Immune Thrombocytopenia (ITP)
  • TPO-RAs
  • TPO-RAs combining anti-CD 20 monoclonal antibody
  • Tianjin, China
    Institute of Hematology and Blood Diseases Hospital, Chinese Aca
Feb 7, 2023

Anti-CGRP Monoclonal Antibody Response After Switching (AMARAS)

Recruiting
  • Migraine
  • Head Pain
    • Valladolid, Spain
      Hospital Clínico Universitario de Valladolid
    Mar 23, 2023

    Metastatic Salivary Gland Carcinoma, Recurrent Salivary Gland Carcinoma, Stage III Major Salivary Gland Cancer AJCC v8 Trial

    Recruiting
    • Metastatic Salivary Gland Carcinoma
    • +4 more
    • New York, New York
      Memorial Sloane Kettering Cancer Center
    Jan 11, 2023

    Colorectal Cancer Trial in New York (mAb hu3S193)

    Terminated
    Has Results
    • Colorectal Cancer
    • monoclonal antibody hu3S193
    • New York, New York
      Memorial Sloan-Kettering Cancer Center
    Oct 3, 2022

    Allergic Rhinitis Trial in Wuhan (GR1802 injection-1, GR1802 injection-2, Placebo)

    Recruiting
    • Allergic Rhinitis
    • GR1802 injection-1
    • +2 more
    • Wuhan, Hubei, China
      Tongji Hosptial affiliated to Tongji Medical college of Huazhong
    Sep 7, 2023

    Solid Tumors Trial (GS-9911, Zimberelimab)

    Not yet recruiting
    • Solid Tumors
    • (no location specified)
    Oct 9, 2023

    NK-T-Cell Lymphoma, Extranodal Trial in Shanghai (4 cycles of ESA regimen with sandwiched radiotherapy, 2 cycles of ESA regimen

    Not yet recruiting
    • NK-T-Cell Lymphoma, Extranodal
    • 4 cycles of ESA regimen with sandwiched radiotherapy
    • +2 more
    • Shanghai, Shanghai, China
      Ruijin Hospital
    Sep 29, 2023

    Advanced Lung Carcinoma Trial in Beijing (LK101 injection (personlized neoantigen pulsed DC vaccine ), Pembrolizumab,

    Recruiting
    • Advanced Lung Carcinoma
    • LK101 injection (personlized neoantigen pulsed DC vaccine )
    • +2 more
    • Beijing, Beijing, China
      Cancer hospital Chinese Academy of Medical Sciences
    May 23, 2023

    Metastatic Lung Non-Small Cell Carcinoma, Refractory Lung Non-Small Cell Carcinoma, Stage IV Lung Cancer American Joint

    Recruiting
    • Metastatic Lung Non-Small Cell Carcinoma
    • +4 more
    • Necitumumab
    • +4 more
    • Los Angeles, California
      UCLA / Jonsson Comprehensive Cancer Center
    Jan 5, 2023

    Thyroid Eye Disease Trial (VRDN-001 10 mg/kg Drug:)

    Not yet recruiting
    • Thyroid Eye Disease
    • VRDN-001 10 mg/kg Drug:
    • (no location specified)
    Sep 7, 2023

    IL-4R Monoclonal Antibody for Chronic Rhino-sinusitis With

    Not yet recruiting
    • Chronic Rhino-sinusitis
    • +3 more
    • IL-4R
    • Placebo
    • Beijing, Beijing, China
      Beijing Tongren Hospital, Capital Medical University
    Jun 17, 2022

    Kidney Cancer Trial in New York (Iodine-131 radiolabeled chimeric mAb G250 (131I-cG250))

    Completed
    Has Results
    • Kidney Cancer
    • Iodine-131 radiolabeled chimeric monoclonal antibody G250 (131I-cG250)
    • New York, New York
      Memorial Sloan-Kettering Cancer Center
    Oct 3, 2022

    Adult Solid Tumor Trial (HLX26, HLX10)

    Recruiting
    • Adult Solid Tumor
    • Xuzhou, Jiangsu, China
      Xuzhou Central Hospital
    Oct 17, 2022

    Solid Tumor, Adult, Lymphoma Trial in Shanghai (HLX26)

    Recruiting
    • Solid Tumor, Adult
    • Lymphoma
    • Shanghai, Shanghai, China
      Fudan University Shanghai Cancer Center
    Jul 10, 2022

    Chronic Inflammatory Disease Trial in London (CBS001, Placebo)

    Suspended
    • Chronic Inflammatory Disease
    • London, United Kingdom
      HMR
    Jan 13, 2023

    Colorectal Cancer Metastatic Trial (HLX26, HLX10)

    Not yet recruiting
    • Colorectal Cancer Metastatic
    • (no location specified)
    Oct 14, 2022

    LAD1 Trial run by the NIAID (Ustekinumab)

    Recruiting
    • LAD1
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Jan 24, 2023

    Advanced Solid Tumors Trial in Shanghai (HLX07+Gemcitabine+Cisplatin, HLX07+Paclitaxel+Carboplatin, HLX07+mFOLFOX6)

    Active, not recruiting
    • Advanced Solid Tumors
    • Shanghai, Shanghai, China
      Shanghai East Hospital
    May 5, 2022

    Solid Tumor, Adult Lymphoma Trial (HLX51)

    Not yet recruiting
    • Solid Tumor, Adult Lymphoma
    • (no location specified)
    Mar 15, 2023

    RSV Infection Trial in Orlando (RSM01, Placebo)

    Completed
    • RSV Infection
    • Orlando, Florida
      PPD Phase I Clinic - Orlando
    Dec 14, 2022

    Metastatic Colon Adenocarcinoma, Metastatic Colorectal Adenocarcinoma, Metastatic Rectal Adenocarcinoma Trial in Scottsdale,

    Not yet recruiting
    • Metastatic Colon Adenocarcinoma
    • +5 more
    • Trastuzumab
    • +2 more
    • Scottsdale, Arizona
    • +2 more
    Jan 31, 2023

    COVID-19 Infection, Hematopoietic and Lymphoid Cell Tumor, Malignant Solid Tumor Trial in Seattle (Questionnaire Administration,

    Suspended
    • COVID-19 Infection
    • +2 more
    • Questionnaire Administration
    • Sotrovimab
    • Seattle, Washington
      Fred Hutch/University of Washington Cancer Consortium
    Jan 24, 2023

    Efficacy of PD-1 Monoclonal Antibody

    Recruiting
    • Esophageal Squamous Cell Carcinoma
    • PD-1 Inhibitor
      • Guangzhou, China
        Nanfang Hospital
      Jul 5, 2022

      Alzheimer Trial in United States (Anti-amyloid Monoclonal Antibodies (mAbs), Standard of Care)

      Not yet recruiting
      • Alzheimer Disease
      • Anti-amyloid Monoclonal Antibodies (mAbs)
      • Standard of Care
      • Albany, Georgia
      • +7 more
      Aug 13, 2023

      Aplastic Anemia Trial in Suzhou (CD20 mAb, ATG)

      Recruiting
      • Aplastic Anemia
      • CD20 monoclonal antibody
      • ATG
      • Suzhou, Jiangsu, China
        The First Affiliated Hospital of Soochow University
      Aug 21, 2022